SCHEMBL19796882

SCHEMBL19796882

C=C(C)C(=O)OCCc1cc(C2CCC(CCCCC)CC2)ccc1-c1ccc2cc(OCCO)ccc2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.34
PTPN11 Q06124 2/20 0.34
FFAR4 Q5NUL3 1/20 0.34
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP9 P14780 1/20 0.33
MMP14 P50281 1/20 0.33
DGAT1 O75907 1/20 0.33
SOAT1 P35610 1/20 0.33
CNR2 P34972 3/20 0.33
CNR1 P21554 2/20 0.33
BCHE P06276 1/20 0.33
SRC P12931 1/20 0.33
KCNH2 Q12809 1/20 0.33
POLB P06746 1/20 0.32
APEX1 P27695 1/20 0.32
HTT P42858 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
S1PR1 P21453 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19797145 0.97 RAB9A (0.34) RAB9APTPN11FFAR4MMP1MMP2
SCHEMBL19796879 0.94 RAB9A (0.39) RAB9APTPN11FFAR4DGAT1SOAT1
SCHEMBL19797121 0.94 RAB9A (0.38) RAB9APTPN11FFAR4DGAT1SOAT1
SCHEMBL19796812 0.93 RAB9A (0.39) RAB9APTPN11FFAR4DGAT1SOAT1
SCHEMBL19797082 0.92 RAB9A (0.37) RAB9APTPN11FFAR4MMP1MMP2
SCHEMBL19797114 0.90 RAB9A (0.39) RAB9APTPN11FFAR4DGAT1SOAT1
SCHEMBL19797146 0.89 FFAR4 (0.34) FFAR4DGAT1SOAT1CNR2CNR1
SCHEMBL17070423 0.89 PPARD (0.33) PTPN11FFAR4DGAT1SOAT1CNR2
SCHEMBL19796870 0.87 FFAR4 (0.36) FFAR4DGAT1SOAT1CNR2CNR1
SCHEMBL19804615 0.87 FFAR4 (0.39) FFAR4MMP1MMP2MMP3MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 RAB9A 4200/4885PTPN11 2304/4885FFAR4 1715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.